1Chapman MA,Lawrence MS,Keats JJ,et al.Initial genome sequenc- ing and analysis of multiple myeloma[J].Nature, 2011,471 ( 7339 ) : 467 - 472.
2L6pez-Corral L,Guti6rrez NC,Vidriales MB,et al.The progression from MGUS to smoldering myeloma and eventually to multiple myeloma involves a clonal expansion of genetically abnormal plasma cells[J].Clin Cancer Res,2011,17(7) : 1692-1700.
3Rajkumar SV, Gupta V, Fonseca R,et al.lmpact of primary molec- ular cytogenetic abnormalities and risk of progression in smoldering multiple myeloma[J].Leukemia, 2013,27 ( 8 ) : 1738-1744.
4Bergsagel PL, Mateos MV, Gutierrez NC, et al.Improving overall survival and overcoming adverse prognosis in the treatment of cytoge- netically high-risk multiple myeloma[J].Blood,2013,121 (6) :884-892.
5Chang H,Qi C,Yi QL,et al.p53 gene deletion detected by fluores- cence in situ hybridization is an adverse prognostic factor for patients with multiple myeloma following autologous stem cell transplantation[J]. Blood, 2005,105 ( 1 ) :358-360.
6Shaughnessy JD,Zhan F,Burington BE,et al.A validated gene expression model of high-risk multiple myeloma is defined by deregu- lated expression of genes mapping to chromosome l[J].Blood,2007,109 (6) : 2276-2284.
